AION Receives FDA Clearance for Its iTempShield Skin-Wearable Device and Software Platform for Professional and Retail Environments
Technology Designed for Multiple Applications, with Initial Focus on Early Infection Detection and Treatment
August 30, 2023 07:05 AM
US FDA grants De Novo approval to Viz.ai's AI algorithm for hypertrophic cardiomyopathy
US FDA grants De Novo approval to Viz.ai's AI algorithm for hypertrophic cardiomyopathy unknown
Viz.ai, the
FDA Updates for the Week of Aug. 14, 2023
FDA Updates for the Week of Aug. 14, 2023 unknown
FDA Approves First Drug for Rare Bone Disorder.
The FDA
Viz.ai gets FDA De Novo approval for AI-enabled heart disease detection
Viz.ai gets FDA De Novo approval for AI-enabled heart disease detection Andrea Fox
The U.S. Food and Drug
Nemaura Medical Announces SFDA Approval of sugarBEAT®
Nemaura Medical Announces SFDA Approval of sugarBEAT® unknown
Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq:
FDA Updates for the Week of July 17, 2023
FDA Updates for the Week of July 17, 2023 unknown
FDA Approves Novel Therapy for Newly Diagnosed AML.
The FDA
FDA Grants Clearance for UltraSight's AI-Powered Cardiac Ultrasound Technology
FDA Grants Clearance for UltraSight's AI-Powered Cardiac Ultrasound Technology unknown Today, UltraSight, a digital health pioneer transforming cardiac
FDA Updates for the Week of July 31, 2023
FDA Approves Lonsurf Combination for Metastatic Colorectal Cancer.
The FDA has approved Lonsurf (trifluridine and tipiracil) as a single agent
FDA Updates for the Week of Aug. 7, 2023
FDA Updates for the Week of Aug. 7, 2023 unknown
FDA Approves Talvey to Treat Multiple Myeloma
The FDA has
Music as medicine: FDA approves stroke damage therapy from Portland startup
Music as medicine: FDA approves stroke damage therapy from Portland startup Hannah LaClaire
Brian Harris is a co-founder and CEO